βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancer

Hum Pathol. 2017 Mar:61:210-220. doi: 10.1016/j.humpath.2016.11.005. Epub 2016 Dec 24.

Abstract

Development of genetic instability is a hallmark of tumor progression. Type III β-tubulin (TUBB3) is a component of microtubules involved in chromosome segregation. Its overexpression has been linked to adverse features of urinary bladder cancer. To investigate the role of TUBB3 for development of genetic instability, we compared TUBB3 expression with histopathological features and surrogate markers of genetic instability and tumor aggressiveness; copy number changes of HER2, TOP2A, CCND1, RAF1, and FGFR1; nuclear accumulation of p53, and cell proliferation in a tissue microarray (TMA) with more than 700 bladder cancers. TUBB3 expression was linked to high-grade and advanced-stage cancers (P<.0001), rapid cell proliferation (P<.0001), presence of multiple gene copy number alterations (P=.0008), and nuclear accumulation of p53 (P=.0008). Strong TUBB3 staining was found in 43% of urothelial cancers harboring copy number alterations as compared with 28% of genetically stable cancers, and in 50% of p53-positive cancers as compared with 30% of p53-negative tumors. The fraction of tumors with concomitant TUBB3 and p53 positivity increased with tumor stage and grade: 2% in pTaG1-2, 11% in pTaG3, 17% in pT1G2, 23% in pT1G3, and 32% in pT2-4 cancers (P<.0001). Importantly, strong TUBB3 overexpression was detectable in about 20% of low-grade, noninvasive cancers. In summary, our study demonstrates that TUBB3 overexpression is linked to an aggressive subtype of urinary bladder cancers, which is characterized by increased genetic instability, p53 alterations, and rapid cell proliferation. Detection of TUBB3 overexpression in genetically stable, low-grade, and noninvasive bladder cancers may be clinically useful to identify patients requiring particular close monitoring.

Keywords: Bladder cancer; Immunochemistry; Prognosis; TUBB3; Tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Biomarkers, Tumor / genetics
  • Biopsy
  • Cell Proliferation
  • DNA Copy Number Variations
  • Gene Dosage
  • Genetic Predisposition to Disease
  • Genomic Instability*
  • Humans
  • Immunohistochemistry
  • Neoplasm Grading
  • Neoplasm Staging
  • Phenotype
  • Tissue Array Analysis
  • Tubulin / analysis*
  • Tumor Suppressor Protein p53 / genetics
  • Up-Regulation
  • Urinary Bladder Neoplasms / chemistry*
  • Urinary Bladder Neoplasms / genetics
  • Urinary Bladder Neoplasms / pathology

Substances

  • Biomarkers, Tumor
  • TP53 protein, human
  • TUBB3 protein, human
  • Tubulin
  • Tumor Suppressor Protein p53